Rising Burden of Herpes Zoster among General Adults and Increased-Risk Groups in Eastern China, 2015–2021: A Population-Based Cohort Study
HZ imposes a rising, age- and risk-concentrated burden in Chinese adults, with PHN being the principal driver of resource use and costs. These real-world estimates support prioritising zoster vaccination for adults ≥ 50 years and clinically vulnerable groups, and integrating HZ surveillance and management within chronic-disease programmes.
Authors
- Zheng Wu (ORCID: https://orcid.org/0000-0002-2441-0229)
- Zhenwei Li
- Zhexin Xu
- Hongbo Lin
- Chuanxi Fu
- Jiajun Li
- Guomin Zhang
- Shenjia Gu
- Kan Chen
Institutions
- Zhejiang Chinese Medical University (CN)
- National Medical Products Administration (CN)
- Ningbo Center for Disease Control and Prevention (CN)
Publication Details
- Journal
- Infectious Diseases and Therapy
- Published
- 2026-02-04
- DOI
- https://doi.org/10.1007/s40121-026-01308-5
- Primary Topic
- Herpesvirus Infections and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00